Home  /  Resource Library  /  Real-world evaluation of ctdna for risk stratification across the spectrum of both aggressive and indolent lymphomas

Real-world evaluation of ctdna for risk stratification across the spectrum of both aggressive and indolent lymphomas

ASH 2025